Skip to main
BTSG

BTSG Stock Forecast & Price Target

BTSG Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrightSpring Health is set to experience continued growth in both revenue and EBITDA, driven by strong performance in its Pharmacy Solutions and Provider Services segments. The company's efficient operations and focus on high-need and high-cost patient populations position it as a leader in the industry, and its expansion into all 50 states provides ample opportunity for future growth. Additionally, the company's excellent balance sheet and solid cash flow indicate strong financial health, making it an attractive investment option.

Bears say

BrightSpring Health is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services, which recently reported negative financial results; despite strong momentum in Specialty and Infusion and a healthy pipeline of drugs converting to generic in the future, BTSG's Pharmacy Solutions revenue and adjusted EBITDA showed underperformance, as it missed expectations by -0.3% and -2.6%, respectively, and the company's 1Q26 gross margin of 13.3% was below Stephens' estimate of 14.5%.

BTSG has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BrightSpring Health Services Inc (BTSG) Forecast

Analysts have given BTSG a Buy based on their latest research and market trends.

According to 10 analysts, BTSG has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $60.30, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $60.30, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BrightSpring Health Services Inc (BTSG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.